Management of acute inflammatory diseases of the upper respiratory tract with cough

Acute inflammatory diseases of the upper respiratory tract (URTI) accompanied by cough are one of the most common groups of diseases in the world. It includes acute respiratory viral infections, often manifested by rhinosinusitis, tonsillopharyngitis and laryngitis. According to statistics, about 90% of all infectious diseases are acute respiratory infections, with cough accompanying acute respiratory infections in 83% of cases. Cough largely determines the severity of the disease, and its duration over 4 weeks indicates a high probability of process chronicity. Cough with difficult to detach sputum dramatically reduces the patient’s quality of life, bringing discomfort in everyday activities. In addition to the cough, the problem of viral diseases lies in the rather difficult diagnosis at the outpatient stage, due to which excessive prescription of antibiotics occurs. In order to avoid the occurrence of complications, chronicization of the disease and reduce the level of inappropriate prescriptions of antibacterial drugs, it is necessary to apply therapy, aimed both at the etiology, the links of pathogenesis, and the symptoms in order to alleviate the condition of the patient and his speedy recovery. The processes leading to the development of cough in URTI are described in the article; principles of differential diagnostics and peculiarities of therapy of URTI are reviewed. The article presents data on the use of a natural remedy, ivy leaf extract, which helps to get rid of cough in a shorter period of time, thereby improving the well-being of the patient, and is notable for its good tolerability and rare occurrence of side effects, which may surpass synthetic alternatives.

1. Daikhes N.A., Baranov A.A., Lobzin Yu.V., Namazova- Baranova L.S., Kozlov R.S., Polyakov D.P. et al. Acute tonsillitis and pharyngitis (Acute tonsillopharyngitis): clinical guidelines. Moscow; 2021. 55 p. (In Russ.) Available at: https://cr.minzdrav.gov.ru/schema/306_2.

2. Chang A.B., Glomb W.B. Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 Suppl.): 260S–283S. https://doi.org/10.1378/chest.129.1_suppl.260s.

3. Shields M.D., Bush A., Everard M.L., McKenzie S., Primhak R. BTS guidelines: Recommendations for the assessment and management of cough in children. Thorax. 2008;63(3 Suppl.):iii1–iii15. https://doi.org/10.1136/thx.2007.077370.

4. Murgia V., Manti S., Licari A., De Filippo M., Ciprandi G., Marseglia G.L. Upper Respiratory Tract Infection-Associated Acute Cough and the Urge to Cough:

5. New Insights for Clinical Practice. Pediatr Allergy Immunol Pulmonol. 2020;33(1):3–11. https://doi.org/10.1089/ped.2019.1135.

6. Delyagin W.M. Cough in children – treat or not treat? Meditsinskiy Sovet. 2018;(2):82–85. (In Russ.) https://doi.org/10.21518/2079-701X-2018-2-82-85.

7. Kryukov A.I., Turovsky A.B. Cough as a symptom of ENT diseases. Lechebnoe Delo. 2008;(4):45–47. (In Russ.) Available at: https://www.atmosphere-ph.ru/modules/Magazines/articles/delo/ld_4_2008_45.pdf.

8. Ovchinnikov A.Yu., Miroshnichenko N.A., Ryabinin V.A. Cough syndrome as a consequence of the pathology of the upper respiratory tract. Asthma and Allergies. 2018;(3):3–5. (In Russ.) Available at: http://www.atmosphere-ph.ru/modules/Magazines/articles/astma/Asthma_3_2018_3.pdf.

9. Kolosova N.G., Shatalina S.I. Antitussive drugs in children’s practice. Meditsinskiy Sovet. 2017;(9):76–79. (In Russ.) https://doi.org/10.21518/2079-701X-2017-9-76-79.

10. Nikiforova G.N., Svistushkin V.M., Zolotova A.V., Morozova M.A. Acute respiratory viral infections: possibilities of symptomatic therapy of patients. Meditsinskiy Sovet. 2021;(4):103–111. (In Russ.) https://doi.org/10.21518/2079701X-2021-4-103-111.

11. Morice A.H., McGarvey L., Pavord I. Recommendations for the management of cough in adults. Thorax. 2006;61(1 Suppl.):i1–24. https://doi.org/10.1136/thx.2006.065144.

12. Chulanov V.P., Gorelov A.V., Malyavin A.G., Zaitsev A.A., Maleev V.V., Arslanova L.V. et al. Acute respiratory viral infections (ARVI) in adults: clinical guidelines. Moscow; 2021. 70 p. (In Russ.) Available at: https://cr.minzdrav.gov.ru/recomend/724_1.

13. Chang A.B., Harrhy V.A., Simpson J., Masters I.B., Gibson P.G. Cough, airway inflammation, and mild asthma exacerbation. Arch Dis Child. 2002;86(4):270–275. https://doi.org/10.1136/adc.86.4.270.

14. Blackwell D.L., Lucas J.W., Clarke T.C. Summary health statistics for U.S. adults: national health interview survey, 2012. Vital Health Stat 10. 2014;(260):1–161. Available at: https://www.cdc.gov/nchs/data/series/sr_10/sr10_260.pdf.

15. Wytske J., Valerie J., Joachim M., Claus B., Alobid I., Baroody F. European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology. 2012;(23):1–298. Available at: http://ieeexplore.ieee.org/document/6673249/.

16. Kenealy T. Sore throat. BMJ. 2014;1–10. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3948435/pdf/2014-1509.pdf.

17. Sidell D., Shapiro N.L. Acute tonsillitis. Infect Disord Drug Targets. 2012;12(4):271–276. https://doi.org/10.2174/187152612801319230.

18. Gore J.M. Acute pharyngitis. JAAPA. 2013;26(2):57–58. https://doi.org/10.1097/01720610-201302000-00012.

19. Bezmenova D.D., Golovko A.A., Kuznetsova Yu.I., Razuvaeva K.A. Sore throat: a pharmacoepidemiological study. Bulletin of Medical Internet Conferences. 2012;(2):99. (In Russ.) Available at: https://medconfer.com/files/archive/2012-02/2012-02-3883-T-1481.pdf.

20. Radtsig E.Yu., Ermilova N.V., Selkova E.P. Laryngitis in children: etiology, treatment and prevention. Pediatrics. Consilium Medicum. 2017;(1):38–40. (In Russ.) Available at: https://omnidoctor.ru/upload/iblock/3de/3dedb6db6d80a93f8db2e8e200854472.pdf.

21. Gladkikh R.A., Molochny V.P., Butakova L.V., Trotsenko O.E., Reznik V.I., Polesko I.V. Clinical and etiological characteristics of acute respiratory viral infections in hospitalized children of the city of khabarovsk in epidemic seasons 2014–2017. Children Infections. 2018;17(2):6–14. (In Russ.) https://doi.org/10.22627/2072-8107-2018-17-2-6-14.

22. Kupchenko A.N., Ponezheva Zh.B. Actual methods’ of diagnosis and treatment ARVI. Russian Archive of Internal Medicine. 2016;6(1):6–12. (In Russ.) https://doi.org/10.20514/2226-6704-2016-6-1-6-12.

23. Polyakova A.S., Bakradze М.D., Tatochenko V.K., Chashchina I.L. Bacterial infections of the upper respiratory tract: how to treat? Meditsinskiy Sovet. 2018;(17):94–102. (In Russ.) https://doi.org/10.21518/2079-701X-2018-17-94-102.

24. Orlova N.V., Suranova T.G. Acute respiratory diseases: progression features, pharmaceutical therapy. Meditsinskiy Sovet. 2018;(15):82–88. (In Russ.) https://doi.org/10.21518/2079-701X-2018-15-82-88.

25. Biserni G.B., Dondi A., Masetti R., Bandini J., Dormi A., Conti F. et al. Immune Response against Adenovirus in Acute Upper Respiratory Tract Infections in Immunocompetent Children. Vaccines (Basel). 2020;8(4):602. https://doi.org/10.3390/vaccines8040602.

26. Pisareva M.M., Eder V.A., Buzitskaya Z.V., Musaeva T.D., Afanaseva V.S., Go A.A. et al. Etiological structure of influenza and other arvi in St. Petersburg during epidemic seasons 2012–2016. Voprosy Virusologii. 2018;63(5):233–239. (In Russ.) https://doi.org/10.18821/0507-4088-2018-63-5-233-239.

27. Lvov D.K., Burtseva E.I., Kolobukhina L.V., Fedyakina I.T., Bovin N.V., Ignatieva A.V. et al. Peculiarities of the influenza and ARVI viruses circulation during epidemic season 2019–2020 in some regions of Russia. Voprosy Virusologii. 2020;65(6):335–349. (In Russ.) https://doi.org/10.36233/0507-4088-2020-65-6-4.

28. Sergeeva I.V., Kamzalakova N.I., Tikhonova E.P., Bulygin G.V. Immunological aspects of acute respiratory viral infections and influenza. Siberian Medical Review. 2012;(6):4–8. (In Russ.) Available at: https://smr.krasgmu.ru/files/28_1418222675_smo_2012,_n6_78_.pdf.

29. Sergeeva I.V., Kamzalakova N.I., Tikhonova E.P., Bulygin G.V. The pathogenesis of acute respiratory viral infections and influenza. Practical Medicine. 2012;(6): 47–50. (In Russ.) Available at: https://www.elibrary.ru/item.asp?id=17952994.

30. Svistushkin V.M., Nikiforova G.N., Shevchik E.A., Zolotova A.V., Pobivantseva A.A. Biocenosis management in the treatment of infectious and inflammatory diseases of the pharynx. Meditsinskiy Sovet. 2020;(16):50–55. (In Russ.) https://doi.org/10.21518/2079-701X-2020-16-50-55.

31. Ababiy I.I., Danilov L.A., Manyuk M.K., Ababiy P.I., Ginda S.S., Trofimchuk M.G. et al. A role of oropharyngeal microbiota in developing acute and chronic diseases of the upper respiratory tract. Russian Journal of Infection and Immunity. 2020;10(2):359–367. (In Russ.) https://doi.org/10.15789/2220-7619-ARO-809.

32. Orlova N.V., Chukaeva I.I. Modern approaches to therapy of acute respiratory viral infections of the upper respiratory tract. Meditsinskiy Sovet. 2017;(5):58–64. (In Russ.) https://doi.org/10.21518/2079-701X-2017-5-58-64.

33. Derbeneva M.L., Guseva A.L. Acute respiratory viral diseases: modern approaches to the diagnosis and treatment. Meditsinskiy Sovet. 2019;(20):32–37. (In Russ.) https://doi.org/10.21518/2079-701X-2019-20-32-37.

34. Berg O., Carenfelt C. Analysis of symptoms and clinical signs in the maxillary sinus empyema. Acta Otolaryngol. 1988;105(3-4):343–349. https://doi.org/10.3109/00016488809097017.

35. Starostina S.V., Sivokhin D.A. Systemic antibiotic therapy of patients with acute bacterial sinusitis taking into account resistance. Meditsinskiy Sovet. 2021;(18): 172–177. (In Russ.) https://doi.org/10.21518/2079-701X-2021-18-172-177.

36. Karneeva O.V., Polyakov D.P. Modern approach to treatment of the upper respiratory tract and middle ear diseases as a prevention of loss hearing. Pediatric Pharmacology. 2012;9(1):30–34. (In Russ.) https://doi.org/10.15690/pf.v9i1.162.

37. Svistushkin V.M., Shevchik E.A. Topical antibacterial therapy in the practice of otolaryngologist. Meditsinskiy Sovet. 2019;(8):10–17. (In Russ.) https://doi.org/10.21518/2079-701X-2019-8-10-17.

38. Kunelskaya N.L., Turovskiy A.B., Luchsheva Yu.V., Khamzalieva R.B., Izotova G.N. The Role of Topical Antibiotics in the Treatment of Diseases with Nasopharyngeal Symptoms. Lechebnoe Delo. 2018;(1):60–65. (In Russ.) https://doi.org/10.24411/2071-5315-2018-11984.

39. Van Houten C.B., Cohen A., Engelhard D., Hays J.P., Karlsson R., Moore E. et al. Antibiotic misuse in respiratory tract infections in children and adults-a prospective, multicentre study (TAILORED Treatment). Eur J Clin Microbiol Infect Dis. 2019;38(3):505–514. https://doi.org/10.1007/s10096-018-03454-2.

40. Kholodova I.N., Syrieva T.N., Kholodov D.I. An integrated approach to the prevention and treatment of ARI. Meditsinskiy Sovet. 2019;(2):61–67. (In Russ.) https://doi.org/10.21518/2079-701X-2019-2-61-67.

41. Kotlukov V.К., Kazyukova T.V., Antipova N.V. Rational antipyretic therapy of arvi in children. Meditsinskiy Sovet. 2018;(17):109–113. (In Russ.) https://doi.org/10.21518/2079-701X-2018-17-109-113.

42. Starostina S.V., Sivokhin D.A. Topical therapy in the treatment of patients with acute rhinosinusitis in adults. Consilium Medicum. 2021;23(3):210–215. (In Russ.) https://doi.org/10.26442/20751753.2021.3.200829.

43. Starostina S.V., Selezneva L.V. Сomplex therapy in patients with acute viral rhinosinusitis. Meditsinskiy Sovet. 2018;(8):94–97. (In Russ.) https://doi. org/10.21518/2079-701X-2018-8-94-97.

44. Egorova O.A. The use of decongestants in children in otorhinolaryngological practice. Pediatrics. Consilium Medicum. 2021;(2):170–176. (In Russ.) https://doi.org/10.26442/26586630.2021.2.200906.

45. Büechi S., Vögelin R., von Eiff M.M., Ramos M., Melzer J. Open trial to assess aspects of safety and efficacy of a combined herbal cough syrup with ivy and thyme. Forsch Komplementarmed Klass Naturheilkd. 2005;12(6):328–332. https://doi.org/10.1159/000088934.

46. Schmidt M., Thomsen M., Schmidt U. Suitability of ivy extract for the treatment of paediatric cough. Phytother Res. 2012;26(12):1942–1947. https://doi.org/10.1002/ptr.4671.

47. Kruttschnitt E., Wegener T., Zahner C., Henzen-Bücking S. Assessment of the Efficacy and Safety of Ivy Leaf (Hedera helix) Cough Syrup Compared with Acetylcysteine in Adults and Children with Acute Bronchitis. Evid Based Complement Alternat Med. 2020:1910656. https://doi.org/10.1155/2020/1910656.

48. Kostev K., Völp A., Ludwig F., Strehl C., Seifert G. Association between ivy leaves dry extract EA 575 prescriptions and antibiotic use, sick leave duration, and repeated infections in adult patients. Postgrad Med. 2022:134(3):333–340. https://doi.org/10.1080/00325481.2022.2015220.